50 Best Peptides

This website is for informational purposes only and does not constitute medical advice. Read disclaimer

#9

Melanotan II

Skin & Anti-AgingMT-2MT-IIMelanotan 2

A synthetic melanocortin peptide that stimulates melanogenesis for skin tanning, also noted for effects on sexual arousal and appetite suppression.

Share:

Overview

Melanotan II (MT-II) is a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (α-MSH), originally developed at the University of Arizona in the 1990s. It was designed to promote melanogenesis — the process by which melanocytes in the skin produce melanin pigment — as a potential strategy for preventing skin cancer by providing a protective tan without UV exposure. The peptide acts as a non-selective agonist at melanocortin receptors MC1R through MC5R.

The broad melanocortin receptor activity of Melanotan II produces multiple physiological effects beyond skin darkening. Users frequently report reduced appetite, increased sexual arousal and spontaneous erections (which led to the development of PT-141/Bremelanotide), and mild fatigue. The tanning effect develops gradually over days to weeks and can persist for extended periods. The skin darkening occurs because MT-II stimulates MC1R on melanocytes, triggering increased production and distribution of eumelanin, the darker form of melanin.

Despite never receiving regulatory approval, Melanotan II has become widely used as an unregulated tanning agent, particularly in countries like Australia, the UK, and Scandinavia. Users are attracted by the prospect of achieving a tan with reduced UV exposure, which theoretically could lower skin cancer risk. However, the relationship between MT-II use, UV exposure, and skin cancer risk has not been adequately studied, and some researchers have raised concerns about potential effects on melanocytic nevi (moles).

Health authorities in multiple countries have issued warnings about Melanotan II due to its unregulated status, potential side effects, and unknown long-term safety profile. Reports of new or changing moles, nausea, facial flushing, and cardiovascular effects have been documented. The peptide remains a subject of ongoing debate regarding its risk-benefit profile, particularly given the availability of safer tanning alternatives and the importance of UV protection in skin cancer prevention.

Research Uses & Applications

  • Stimulation of melanogenesis for skin tanning with reduced UV exposure
  • Research into melanocortin system's role in pigmentation
  • Observed appetite suppression effects
  • Early research that led to development of PT-141 for sexual dysfunction
  • Investigated as a potential protective strategy against UV-induced skin damage

Key Research Findings

  • Clinical studies showed Melanotan II significantly increased skin melanin density and produced visible tanning in fair-skinned individuals with reduced UV exposure.
  • Research at the University of Arizona demonstrated dose-dependent increases in melanin production through MC1R activation on melanocytes.
  • Studies documented pro-erectile effects in men, which directly led to the development of bremelanotide (PT-141) for sexual dysfunction.
  • Case reports and surveillance data have documented changes in melanocytic nevi (moles) in MT-II users, raising dermatological surveillance concerns.
  • Research showed appetite-suppressing effects through central melanocortin MC4R activation.

Risks & Side Effects

  • Nausea is very common, especially with initial doses, and can be significant.
  • Changes to existing moles and development of new nevi have been reported, requiring dermatological monitoring.
  • Facial flushing, fatigue, and injection site reactions are frequently reported.
  • Long-term effects on melanocyte behavior and potential melanoma risk are not well characterized.
  • Unregulated manufacture means product quality, purity, and sterility cannot be guaranteed.

Administration

Typically administered via subcutaneous injection. Common protocols involve a loading phase of 0.25-0.5 mg daily for 2-3 weeks, followed by maintenance doses of 0.5 mg once or twice weekly. Some users begin with lower doses (0.1 mg) to assess tolerance due to nausea. Nasal spray formulations also exist but have lower bioavailability. Mild UV exposure is generally considered necessary to activate the tanning response.

Legal Status

Melanotan II is not approved by any major regulatory agency for human use. It is illegal to sell for human consumption in many countries including Australia, the UK, and across the EU. Health authorities in multiple countries have issued public warnings against its use. It can be found as a research chemical but its sale for personal use is restricted or prohibited in many jurisdictions.

Frequently Asked Questions

What is Melanotan II?

A synthetic melanocortin peptide that stimulates melanogenesis for skin tanning, also noted for effects on sexual arousal and appetite suppression.

What are the main uses of Melanotan II?

The primary research applications of Melanotan II include: Stimulation of melanogenesis for skin tanning with reduced UV exposure; Research into melanocortin system's role in pigmentation; Observed appetite suppression effects; Early research that led to development of PT-141 for sexual dysfunction; Investigated as a potential protective strategy against UV-induced skin damage.

What are the risks and side effects of Melanotan II?

Documented risks and side effects include: Nausea is very common, especially with initial doses, and can be significant.; Changes to existing moles and development of new nevi have been reported, requiring dermatological monitoring.; Facial flushing, fatigue, and injection site reactions are frequently reported.; Long-term effects on melanocyte behavior and potential melanoma risk are not well characterized.; Unregulated manufacture means product quality, purity, and sterility cannot be guaranteed.. Always consult a healthcare professional before considering any peptide.

Is Melanotan II legal?

Melanotan II is not approved by any major regulatory agency for human use. It is illegal to sell for human consumption in many countries including Australia, the UK, and across the EU. Health authorities in multiple countries have issued public warnings against its use. It can be found as a research chemical but its sale for personal use is restricted or prohibited in many jurisdictions.

How is Melanotan II administered?

Typically administered via subcutaneous injection. Common protocols involve a loading phase of 0.25-0.5 mg daily for 2-3 weeks, followed by maintenance doses of 0.5 mg once or twice weekly. Some users begin with lower doses (0.1 mg) to assess tolerance due to nausea. Nasal spray formulations also exist but have lower bioavailability. Mild UV exposure is generally considered necessary to activate the tanning response.

Related Peptides

#8

GHK-Cu

Skin & Anti-Aging

#16

Epithalon

Skin & Anti-Aging

#103

Copper Tripeptide-1

Skin & Anti-Aging

#10

AOD-9604

Weight Management

Stay Updated on Peptide Research

Get the latest peptide research news and updates delivered to your inbox.

Official Store

Experience Peptides on Your Skin

Shop our curated collection of peptide-infused skincare — Copper Peptide serums, anti-aging treatments, hydrogel patches, and more.

Shop Peptide Skincare

Important Disclaimer

The information on this page is for educational and informational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional before considering any peptide or supplement. 50 Best Limited does not endorse, recommend, or promote the use of any peptide for self-administration. Read our full disclaimer.

← #8 GHK-Cu#10 AOD-9604 →